327056-72-4 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 3-chloro-5-cyanobenzoate is used as an active pharmaceutical ingredient for its antimicrobial and pesticidal properties, contributing to the development of medications that combat harmful microorganisms and pests.
Used in Agricultural Products:
In the agricultural sector, methyl 3-chloro-5-cyanobenzoate is utilized as a key component in pesticides and antifungal agents, leveraging its inhibitory effects on the growth of unwanted organisms to protect crops and enhance agricultural yields.
Used as an Intermediate in Organic Synthesis:
Methyl 3-chloro-5-cyanobenzoate serves as an intermediate in the synthesis of other organic compounds, playing a pivotal role in the production of a diverse range of chemical products due to its distinctive chemical characteristics.
It is crucial to handle methyl 3-chloro-5-cyanobenzoate with caution, as improper management may lead to health and environmental risks.
Check Digit Verification of cas no
The CAS Registry Mumber 327056-72-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,7,0,5 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 327056-72:
(8*3)+(7*2)+(6*7)+(5*0)+(4*5)+(3*6)+(2*7)+(1*2)=134
134 % 10 = 4
So 327056-72-4 is a valid CAS Registry Number.
327056-72-4Relevant academic research and scientific papers
IMINOPYRIDINE DERIVATIVE AND USE THEREOF
-
Page/Page column 72, (2009/07/18)
Provided are an iminopyridine derivative having a selective α1D adrenergic receptor antagonistic action and useful as an agent for the prophylaxis or treatment of a lower urinary tract disease and the like, and a screening method for a compound
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
-
, (2008/06/13)
The present invention provides compounds and pharmaceutical compositions that act as antagonists at metabotropic glutamate receptors, and that are useful for treating neurological diseases and disorders. Methods of preparing the compounds also are disclosed.
